These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29417946)

  • 1. MicroRNAs as biomarkers for human glioblastoma: progress and potential.
    Huang SW; Ali ND; Zhong L; Shi J
    Acta Pharmacol Sin; 2018 Sep; 39(9):1405-1413. PubMed ID: 29417946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.
    Saadatpour L; Fadaee E; Fadaei S; Nassiri Mansour R; Mohammadi M; Mousavi SM; Goodarzi M; Verdi J; Mirzaei H
    Cancer Gene Ther; 2016 Dec; 23(12):415-418. PubMed ID: 27834360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.
    Manterola L; Guruceaga E; Gállego Pérez-Larraya J; González-Huarriz M; Jauregui P; Tejada S; Diez-Valle R; Segura V; Samprón N; Barrena C; Ruiz I; Agirre A; Ayuso A; Rodríguez J; González A; Xipell E; Matheu A; López de Munain A; Tuñón T; Zazpe I; García-Foncillas J; Paris S; Delattre JY; Alonso MM
    Neuro Oncol; 2014 Apr; 16(4):520-7. PubMed ID: 24435880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA-137 is a potential biomarker for human glioblastoma.
    Li HY; Li YM; Li Y; Shi XW; Chen H
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3599-604. PubMed ID: 27649660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients.
    Géczi D; Nagy B; Szilágyi M; Penyige A; Klekner Á; Jenei A; Virga J; Birkó Z
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
    Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
    Ahir BK; Ozer H; Engelhard HH; Lakka SS
    Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21: A key player in glioblastoma pathogenesis.
    Masoudi MS; Mehrabian E; Mirzaei H
    J Cell Biochem; 2018 Feb; 119(2):1285-1290. PubMed ID: 28727188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of the regulation roles of MicroRNA in glioblastoma.
    Yan C; Kong X; Gong S; Liu F; Zhao Y
    Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
    Chen J; Yang L; Wang X
    Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
    Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
    EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
    Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
    J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer.
    Alves Dos Santos K; Clemente Dos Santos IC; Santos Silva C; Gomes Ribeiro H; de Farias Domingos I; Nogueira Silbiger V
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.
    Lan Z; Li X; Zhang X
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer.
    Hasanzadeh M; Movahedi M; Rejali M; Maleki F; Moetamani-Ahmadi M; Seifi S; Hosseini Z; Khazaei M; Amerizadeh F; Ferns GA; Rezayi M; Avan A
    J Cell Physiol; 2019 Feb; 234(2):1289-1294. PubMed ID: 30191988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy.
    Garcia CM; Toms SA
    World Neurosurg; 2020 Jun; 138():425-435. PubMed ID: 32251831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
    Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
    Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.